Stem Cell Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Treatment
Research from Germany, Netherlands and Egypt add new data to cancer treatment body of knowledge
August 14th, 2006
New findings from Germany, Netherlands and Egypt describe advances in cancer treatment. Study 1: Repetitive high dose-chemotherapy with escalated CHOP plus etoposide is feasible and effective in patients with aggressive non-Hodgkin lymphoma. According to recent research from Germany, "Feasibility, safety, and efficacy of a 4-course high-dose chemotherapy (HDT) protocol including autologous stem cell transplantation (SCT) after courses 2, 3, and 4 was investigated in 110 patients, aged 18 to 60 years, with primary diagnosis of aggressive NHL (aNHL), and lactic dehydrogenase (LDH) levels above normal. "At dose level 1 (DL1), course...
Source: Stem Cell Week (2006-08-14)
|
